E.coli-derived human Dysbindin/DTNBP1 recombinant protein (Position: M1-S351). Human Dysbindin/DTNBP1 shares 79.4% and 78.6% amino acid (aa) sequence identity with mouse and rat Dysbindin/DTNBP1, respectively.
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Purity:
Immunogen affinity purified.
Form:
Liquid
Target:
Dysbindin
Application Dilute:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* VAT and and shipping costs not included. Errors and price changes excepted